Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal FADD Primary Antibody for WB - ABIN1881331
Papoff, Trivieri, Crielesi, Ruberti, Marsilio, Ruberti: FADD-calmodulin interaction: a novel player in cell cycle regulation. in Biochimica et biophysica acta 2010
Show all 5 Pubmed References
Human Polyclonal FADD Primary Antibody for IP, WB - ABIN222894
Chen, Texada, Duggan, Liang, Reden, Kooragayala, Langford: Surface calreticulin mediates muramyl dipeptide-induced apoptosis in RK13 cells. in The Journal of biological chemistry 2005
Show all 3 Pubmed References
Human Polyclonal FADD Primary Antibody for IHC (p), WB - ABIN669471
Soni, Adebiyi: Early septic insult in neonatal pigs increases serum and urinary soluble Fas ligand and decreases kidney function without inducing significant renal apoptosis. in Renal failure 2016
Human Polyclonal FADD Primary Antibody for IHC, WB - ABIN2792110
Thomas, Henson, Reed, Salsbury, Thorburn: Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD. in The Journal of biological chemistry 2004
Overexpression of FADD and Caspase-8 (show CASP8 Antibodies) suppresses proliferation whilst promoting the apoptosis of human GBM cells.
FADD expression and its phosphorylation can be reliable biomarkers with prognostic value for T-cell lymphoblastic lymphoma stratification.
FADD interference down-regulated Rheb (show RHEB Antibodies) expression and repressed mTORC1 activity in breast cancer cell lines. The autophagy was induced by FADD deficiency in MCF7 or MDA-231 cells but rescued by recovering Rheb (show RHEB Antibodies) expression.
The present data suggests FADD as a putative biomarker for pathological processes associated with the course of clinical dementia.
at normal levels of expression during bacterial infection, NleB1/NleB(CR) antagonizes death receptor-induced apoptosis of infected cells by modifying FADD in an irreversible manner.
Caspase-8 can serve in two distinct roles in response to TRAIL receptor engagement, as a scaffold for assembly of a Caspase-8-FADD-RIPK1 "FADDosome" complex, leading to NFkappaB-dependent inflammation, or as a protease that promotes apoptosis.
Using the tDED filament structure as a template, structural analyses reveal the interaction surfaces between FADD and caspase-8 (show CASP8 Antibodies) and the distinct mechanisms of regulation by cFLIP (show CFLAR Antibodies) and MC159 through comingling and capping, respectively.
This study reveals an essential role of SUMOylated FADD in Drp1 (show CRMP1 Antibodies)- and caspase-10 (show CASP10 Antibodies)-dependent necrosis.
In myelodysplastic syndrome, FADD expression is regulated by SPAG6 (show SPAG6 Antibodies) which influences its interaction with TRAIL death receptors.
High levels of FADD and caspase-8 (show CASP8 Antibodies), but not caspase-3 (show CASP3 Antibodies), were associated with increased incidence of coronary events in subjects from the general population.
results show that N-FADD is a more potent apoptotic inducer and VNP20009-mediated targeted expression of N-FADD provides a possible cancer gene therapeutic approach for the treatment of melanoma.
these results demonstrated that RIPK3-mediated signaling in Tie-2 expressing cells was responsible for the embryonic lethality of Fadd-/- with cardiac failure.
The study provides genetic evidence that different RIP1 kinase inactive mutations have distinct impacts on the embryogenesis of Fadd-deficient mice.
Our findings reveal that MLKL and FADD play critical roles in preventing lymphoproliferative disease and activating the NLRP3 (show NLRP3 Antibodies) inflammasome
miR (show MLXIP Antibodies)-7a was a necessary mediator in FADD-regulated FAK (show PTK2 Antibodies) expression. In contrast to its classical apoptotic role, FADD interference could reduce the rate of cell migration, which could be rescued by inhibiting miR (show MLXIP Antibodies)-7a expression.
In macrophages, ultraviolet radiation induced association of MyD88 with FADD and migration of FADD to the cell membrane
The authors conclude that FADD is a master regulator of glucose and fat metabolism.
Mice deficient in RIPK3 (show RIPK3 Antibodies) or doubly deficient in MLKL and FADD, but not MLKL alone, are more susceptible to influenza A virus than their wild-type counterparts, revealing an important role for RIPK3 (show RIPK3 Antibodies)-mediated apoptosis in antiviral immunity.
Wild-type cells can execute apoptosis via both, the mitochondrial and the receptor-mediated pathway whereas FADD-deficient cells can only activate the intrinsic pathway. There is a difference in UVC radiation response between two cell lines indicating the role of FADD in the selection of cell death modality.
FADD induces apoptosis
mapping and sequencing of bovine FADD cDNA, and characterization of its expression in endothelial cells
FADD has multiple functions in embryos; it plays a part in the regulation of NF-kappaB (show NFKB1 Antibodies) activation and heart formation, in addition to apoptosis.
The FADD protein shows evolutionary conservation.
Interaction of xFADD and xRIP1 induced synergistic activation of JNK (show MAPK8 Antibodies) and NF-kappaB (show NFKB1 Antibodies).
establish that pax2 in combination with vax2 directly regulate the fas-associated death domain (fadd) gene
The protein encoded by this gene is an adaptor molecule that interacts with various cell surface receptors and mediates cell apoptotic signals. Through its C-terminal death domain, this protein can be recruited by TNFRSF6/Fas-receptor, tumor necrosis factor receptor, TNFRSF25, and TNFSF10/TRAIL-receptor, and thus it participates in the death signaling initiated by these receptors. Interaction of this protein with the receptors unmasks the N-terminal effector domain of this protein, which allows it to recruit caspase-8, and thereby activate the cysteine protease cascade. Knockout studies in mice also suggest the importance of this protein in early T cell development.
Fas-associating death domain-containing protein
, Fas-associating protein with death domain
, growth-inhibiting gene 3 protein
, mediator of receptor induced toxicity
, mediator of receptor-induced toxicity
, protein FADD
, FAS-associated death domain protein
, FAS-associating death domain-containing protein
, Fas (TNF receptor superfamily, member 6)
, Fas-associated via death domain
, Fas (TNFRSF6)-associated via death domain
, Fas associated via death domain S homeolog